Lilly's bowel disease drug gets US FDA nod for treatment in adults - Reuters

* Lilly's bowel disease drug gets US FDA nod for treatment in adults  Reuters
* FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company  Investors | Eli Lilly and Company
* FDA approves Eli Lilly ulcerative colitis treatment Omvoh - STAT  STAT
* FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis  PR Newswire
* FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis  Yahoo Finance
* View Full Coverage on Google News


http://dlvr.it/Sy1NNp